Mohamed Abazeed, MD, PhD

216.444.5571

Mohamed Abazeed, MD, PhD

Appointed: 2013

Mohamed Abazeed, MD, PhD
Department: Radiation Oncology
Associate Staff
Location: Cleveland Clinic Main Campus
Mail Code R40
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.5571
Mohamed Abazeed, MD, PhD
Department: Translational Hematology and Oncology Research
Associate Staff
Location: Cleveland Clinic Main Campus
Mail Code R40
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.5571
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Mohamed Abazeed, MD, PhD, received his medical and doctoral degrees from the University of Michigan in Ann Arbor, Michigan and completed his residency training in Radiation Oncology at the Harvard Radiation Oncology Program in Boston, Massachusetts.

In addition to being eminently trained in clinical care, he is engaged in an ambitious program to develop personalized treatments that reflect our patients’ uniqueness.

Education & Fellowships

Residency - Brigham & Women's Hospital
Radiation Oncology
Boston, MA
2013
Internship - Saint Joseph Mercy Health System
Transitional
Ann Arbor, MI USA
2009
Medical School - University of Michigan Medical School
Ann Arbor, MI USA
2008
Doctorate - University of Michigan
Ann Arbor, MI USA
2008
Undergraduate - University of Michigan
Ann Arbor, MI USA
2000

Certifications

  • Radiation Oncology

Specialty Interests

Lung and Gastro-intestinal Cancer; 3D-Conformal External Beam Radiotherapy, Intensity Modulated Radiotherapy, Image Guidance, and Stereotactic Body Radiotherapy

Awards & Honors

2000 Graduate with Highest Distinction, BS, University of Michigan

2003 Genetics Training Grant Award, PhD, University of Michigan

2004 Most Outstanding Graduate Student, University of Michigan

2006 Most Outstanding PhD Dissertation, University of Michigan

2008 Graduate with Distinction in Research, MD, PhD

2011 B. Leonard Holman Fellow, Harvard Radiation Oncology Program

2011 Pathobiology of Cancer at the Host and Population Level Grant Award, Dana-Farber Cancer Institute

2012 ASTRO Annual Resident Award

Innovations & Patents

Title of Invention: Compositions and methods for sensitizing a neoplastic cell to radiation. (2013).

Memberships

  • American Society for Therapeutic Radiation and Oncology       
  • American College of Radiology
  • American Society of Clinical Oncology
  • American Association for Cancer Research
  • Radiological Society of North America

Treatment & Services

  • Biologically Targeted Radiotherapy
  • Experimental Therapeutics
  • External Beam Radiotherapy
  • Genomic Medicine
  • Hyperfractionated Radiation Therapy
  • Image Guided Radiation Therapy
  • Intensity Modulated Radiation Therapy
  • Stereotactic Body Radiotherapy

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 1/31/2014, Dr. Abazeed has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
Cleveland Clinic Mobile Site